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Background: Fibroblast specific protein-1 (S100A4) is related with many fibrotic diseases, but its role in the pathogenesis
of pleural fibrosis has not been fully elucidated. Then we aim to investigate the expression and effect of fibroblast
specific protein-1 (S100A4) in pleural tuberculosis and, subsequently, pleural fibrosis.
Methods: The expression of S100A4 in pleura was examined in 30 patients with pleural tuberculosis and 5 control
(disease-free) patients by immunohistochemistry using the streptavidin-peroxidase (S-P) conjugated method.
Results: The expression of S100A4 in pleura was mainly distributed in the nucleus and cytoplasm of fibroblasts and
vascular endothelial cells, and the positive rate was 90.0% (27 out of 30 patients with pleural tuberculosis). There were
no expressions of S100A4 in the control group. In the pleura of all 30 patients with pleural tuberculosis, S100A4 had a
higher expression in the two- to eight-week duration of the disease.
Conclusions: S100A4 plays an important role in the phenotypic transformation of pleural mesothelial cells and the
development of pleural fibrosis.
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Incidences of pleural fibrosis are not rare and may cause
restrictive ventilation dysfunction, which significantly re-
duces patients’ quality of life. Pneumonia, parapneumonic
effusion, empyema, pulmonary tuberculosis, and pleural
tuberculosis are the most common causes of pleural fibro-
sis, especially pleural tuberculosis. It is known that pleural
mesothelial cell transition into myofibroblasts (MMT)
plays an important role in the pathogenesis of pleural
fibrosis. However, the pathogenesis of pleural fibrosis has
not been fully elucidated yet.
Fibroblast specific protein-1 (S100A4) is a member of
the S100 family of proteins containing 2 EF-hand calcium-
binding motifs, known as a metastasis-associated protein,
whose chromosomal rearrangements and altered ex-
pression have been implicated in tumor metastasis [1].
However, recent studies have linked S100A4 to some* Correspondence: sunzm67@sohu.com
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unless otherwise stated.fibrotic diseases [2], and it is reported that S100A4
contributes to the pathogenesis of oral submucous fibrosis
[3]. There is also research evidencing that S100A4 modu-
lates the p53 function in fibroblasts to mediate myocardial
interstitial fibrosis [4]. So far, the role of S100A4 in the
pathogenesis of pleural fibrosis resulting from pleural
tuberculosis has not been reported.
Our study was designed to investigated the expression
of S100A4 in pleural tuberculosis and analyze its relation-
ship to the clinical course of pleural tuberculosis, aiming
to explore the potential mechanism of pleural fibrosis
caused by pleural tuberculosis.Methods
Source of specimen
The study was approved by the Research Ethics Committee
of the First Affiliated Hospital of the Medical College of
Xi'an Jiaotong University (People’s Republic of China) and
written informed consent was obtained from all patients
before the procedure.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cases, among them, 30 cases were from pleural tuberculosis
patients, and the other 5 cases were from normal pleural
tissue. The samples are got by the percutaneous needle
pleural biopsy or surgical operation in First Affiliated
Hospital of Medical College of Xi'an Jiaotong University
from June, 2011 to June 2012.
Among the 30 patients with pleural tuberculosis, 14
cases are male, and 16 cases are female, aged between 14
to 53 years old. 5 normal cases included 3 males and 2
females, age ranged 13 to 40 years old.
Methods and reagents
Paraffin-embedded tissue sections were made, roughly
4 μm in size. In order to review the diagnosis, one section
was processed using S100A4 dyeing and the other was
processed using hematoxylin and eosin dyeing.
Rabbit anti-human S100A4 polyclonal antibody (Neo-
marker, Fremont, CA, USA) is used for S100A4 dyeing.l.
The broad spectrum allergic S-P kit and Diaminobenzidine
(DAB) chromogenic liquid were purchased from Fuzhou
Mai'xin biotechnology company (Fuzhou, China). S100A4
was detected referring to the S-P immunohistochemistry
kit instructions. A known S100A4-positive tonsil slice was
made as a positive control, and phosphate buffer solution
(PBS) used instead of the primary antibodies for a negative
control.
Double-blind method to view the slices
Yellow granules in cytoplasm or in the nucleus were
considered as positive cells. The Fromwitz comprehensive
scoring method [5] for protein accumulation was slightly
modified to process a semi-quantitative analysis. Under a
high magnification (10 × 40), 10 different fields were ran-
domly selected with 100 cells in each field. We then calcu-
lated the positive cell percentage (positive cells/total
number of cells). Positive percentage scoring was as fol-
lows: ≤ 5% for 0 point, 6 to 25% for 1 point, 26 to 50% for
2 points, 51 to 75% for 3 points, >75% for 4 points. We
applied a tinting strength score for the staining of positive
cells: light brown for 1 point, brown for 2 points, and deep
brown for 3 points. The process comprehensive scoring
(positive percentage score and tinting strength score are
calculated respectively, then summed.) was as follows: 0 to
1 point was negative (−), 2 to 3 points was weakly positive
(+), 4 to 5 points was moderately positive (+ +), and 6 to 7
points was strong positive (+ + +).
Statistical analysis
SPSS13.0 statistical software (SPSS Inc, Chicago, IL,USA)
was used perform the statistical analysis. The rank-sum
test (Kruskal-Wallis test), and pairwise comparison with
the Bonferroni method was used (P <0.05 was considered
to be statistically significant). One-way analysis of variance(ANOVA), and pairwise comparison using the least
significance difference (LSD) method was performed
(P <0.05 was considered to be statistically significant).
Results
S100A4 expression orientation
S100A4-positive expression in pleural tissue showed as
claybank granules under high magnification. The results
revealed that S100A4 was mainly located in the cytoplasm
and nucleus of interstitial fibroblasts and vascular endo-
thelial cells. The positive cells were unevenly distributed,
with often focal or patchy distribution. The total positive
rate was 90.0% (27 out of 30 patients with pleural tubercu-
losis). The expression of S100A4 in normal pleural tissues
was negative (showed as Figure 1).
The relationship between S100A4 expression and the
course of pleural tuberculosis
The expression of S100A4 is closely associated with the
clinical course of pleural tuberculosis (showed in Table 1).
In cases for which the clinical course were between two to
eight weeks, the expressions were all positive and the
comprehensive score was highest, compared with other
patients group.
Discussion
Our study found that S100A4 was significantly expressed
in pleural tuberculosis, and was closely associated with
the clinical course of pleural tuberculosis, while it did
not express in normal pleural tissue.
In China, tuberculous pleural effusion accounts for
about 50% of the total pleural effusion. Although regular
anti-tuberculosis treatment is available, there are still 30
to 50% of tuberculous pleural effusion patients progres-
sing to pleural thickening and adhesion [6]. Pleural fibrosis
can have a certain degree influence on the body, some
may cause fibrothorax and lead to respiratory dysfunction.
At present, there is no effective method to cure pleural
fibrosis. In recent years, the mechanism of pleural
thickening and adhesion has been controversial. Some
researchers present that the pleural thickening degree
is associated with elevated protein and adenosine deami-
nase (ADA) in pleural effusion [7]. While some researchers
oppose this view, and instead present that the decrease of
PH and glucose in the thoracic liquid is associated with
pleural thickening [8]. Studies have also shown that the
pleural mesothelium cells (PMCs), cytokines, and fibrino-
lytic and/or coagulation system play an important role in
the pathogenesis of pleural fibrosis [9,10].
PMCs can respond to some signals in the microenvir-
onment and secrete glycosaminoglycan and surfactant to
reduce the friction between visceral pleura and parietal
pleura. Besides this, PMCs also have other biological
behaviors to avoid pleural thickening and adhesion, for
Figure 1 The expression of S100A4 in pleural tissue. (A) HE stained of tuberculous pleurisy (10 × 10). (B) S100A4 protein expression in
tuberculous pleurisy in cell cytoplasm and nucleus, stained by S-P method (10 × 10). The S100A4 positive cells are brown. (C) HE stained of normal
pleural tissue (10 × 10). (D) No brown cells were observed. S100A4 protein is not expressed in normal pleural tissues, stained by S-P
method (10 × 10).
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and out of the serous cavity, inflammation reaction,
growth factors and collagen releasing to repair damage,
and protease and fibrinolytic enzyme-releasing. Huggins
et al. presented that the response of PMCs to injury and
its ability, along with the basement membrane, to main-
tain its integrity is vital in determining whether there is
normal healing or pleural fibrosis [11]. The research of
Antony [12] showed that fibroblast growth factor (bFGF)
produced by PMCs can affect pleural fibrosis. Nathalie
[13] transferred TGF-β1 into the pleural mesothelium cell
of rats by adenovirus gene transfection, which induced
the occurrence of pleural fibrosis and caused serious
lung capacity limits. The results also showed that pleural
fibrosis was associated with PMCs phenotypic transform-
ation to α-SMA-positive myofibroblasts, called mesothelial-
fibroblastoid transformation.
TGF-β is an important pro-fibrosis factor and plays an
important role in fibrosis of many organs. Studies haveTable 1 The relationship between S100A4 expression and






- + ++ +++
<2 weeks 11 3 5 1 2 0.09a
2-8 weeks 13 0 1 7 5 0.01b
>8 weeks 6 0 6 0 0
a:<2 weeks vs. 2-8 weeks; b: 2-8 weeks vs. >8 weeks. Both are calculated by
rank-sum test.shown that TGF-β can induce the occurrence of
epithelial-mesenchymal transition (EMT) [14]. Lung tissue
transient overexpression of TGF-β1 can induce pulmonary
fibrosis [15]. TGF-β can also lead to the occurrence of
pleural fibrosis by increasing the production of extracellular
matrix and decreasing its degradation [16]. Myofibroblasts
are a cell type that between fibroblasts and smooth muscle
cells, it retains the biological characteristics of fibroblasts
to synthesize collagen, which is the main source of extra-
cellular matrix in organs fibrosis, and the contraction
characteristics of smooth muscle cells. Kim et al. showed
that pleural mesothelial cells treated with TGF-β1 would
lose the epithelial morphology and gain epithelial and
mesenchymal characteristics. This shows that the pleural
mesothelial cells in pleural tuberculosis participated in
pleural fibrosis through EMT [17].
In 1995, S100A4 was found to especially be expressed
in fibroblasts and named it fibroblast specific protein-1
[18]. S100A4 is a calcium-binding protein which has an
EF double helix structure, and together with another 19
members, composes the S100 family. It participates in
signal transduction inside and outside the cell, cell
proliferation and differentiation, intercellular adhesion
and cell movement, and many other physiological pro-
cesses. For more than 10 years, many studies have
shown that S100A4 plays an important role in tumor
metastasis [19]. Recent studies have also shown that
TGF-β1 can regulate the expression of S100A4, and
cancer cells invasion mediated by TGF-β1 could be
inhibited by S100A2 silence, indicating that S100A4
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metastasis [20].
Conclusions
Our study found that S100A4 was positively expressed
in pleural tuberculosis, mainly in the fibroblasts and not
in normal pleural tissue. This result suggests that pleural
interstitial cells may increase in pleural tuberculosis, con-
sistent with prior research conclusions. Therefore, S100A4
may play an important role in the phenotype transform-
ation of pleural mesothelium cells and pleural fibrosis. But
whether pleural mesenchymal cells derive from epithelial
cells via EMT during the process of pleural fibrosis, and
the potential role of TGF-β and S100A4 in this warrant
further study.
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